Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Toshie Kusunoki"'
Autor:
Jun Shimizu, Tadahiro Sasaki, Ritsuko Koketsu, Ryo Morita, Yuka Yoshimura, Ami Murakami, Yua Saito, Toshie Kusunoki, Yoshihiro Samune, Emi E. Nakayama, Kazuo Miyazaki, Tatsuo Shioda
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Many therapeutic antibodies (Abs) and mRNA vaccines, both targeting SARS-CoV-2 spike protein (S-protein), have been developed and approved in order to combat the ongoing COVID-19 pandemic. In consideration of these developments, a common con
Externí odkaz:
https://doaj.org/article/8a37b41caa644a66a3c211598c57d82d
Autor:
Jun Shimizu, Tadahiro Sasaki, Ritsuko Koketsu, Ryo Morita, Yuka Yoshimura, Ami Murakami, Yua Saito, Toshie Kusunoki, Yoshihiro Samune, Emi E. Nakayama, Kazuo Miyazaki, Tatsuo Shioda
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/e7a68de209cf4da4a6b4dc491395788c
Autor:
Kiyotoshi Sekiguchi, Akinori Yuzuriha, Takuya Matsumoto, Koji Eto, Sou Nakamura, Toshie Kusunoki, Naoshi Sugimoto
Publikováno v:
Blood. 132:3845-3845
[Background] Human pluripotent stem cell (hPSC) technology enables regenerative transplantation therapy and establishment of in vitro disease models. hPSCs can be maintained to proliferate limitlessly and also differentiated to specific lineage cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f8b5e43247a85dd31842a4f7d472406
https://doi.org/10.1182/blood-2018-99-114505
https://doi.org/10.1182/blood-2018-99-114505